Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks

“ARRIAH-AviFluVac” vaccine against H5 avian influenza was demonstrated to be effective for  ducks, geese and turkeys both in the laboratory and production environment. When administered to ducks at 0.5; 1.0 and 1.5 cm3, the vaccine provided 100%-effective protection of birds against the disease and...

Full description

Saved in:
Bibliographic Details
Main Authors: N. V. Moroz, S. V. Frolov, V. N. Irza, L. O. Scherbakova, V. Yu. Kulakov
Format: Article
Language:English
Published: Da Vinci Media 2024-09-01
Series:Ветеринария сегодня
Subjects:
Online Access:https://veterinary.arriah.ru/jour/article/view/845
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832086680412094464
author N. V. Moroz
S. V. Frolov
V. N. Irza
L. O. Scherbakova
V. Yu. Kulakov
author_facet N. V. Moroz
S. V. Frolov
V. N. Irza
L. O. Scherbakova
V. Yu. Kulakov
author_sort N. V. Moroz
collection DOAJ
description “ARRIAH-AviFluVac” vaccine against H5 avian influenza was demonstrated to be effective for  ducks, geese and turkeys both in the laboratory and production environment. When administered to ducks at 0.5; 1.0 and 1.5 cm3, the vaccine provided 100%-effective protection of birds against the disease and death after challenge with the relevant high pathogenicity avian influenza virus of subtype H5N1, clade 2.3.4.4b. Singular 0.5–1.5 cm3 inoculation induced formation of antibodies, which were detected in the hemagglutination inhibition test at the titres that ranged from 4.3 to 6.1 log2. The vaccine facilitated 9–26-fold decrease in the virulent virus shedding by the ducks. Protection of turkeys vaccinated at the dose of 1.0 cm3 was maintained at the level of 87.5% after challenge with high pathogenicity avian influenza virus of subtype H5N1, clade 2.3.4.4b. The vaccine induced formation of antibodies at the titres of 4.9 and 5.5 log2 in turkeys after singular and double vaccination at the dose of 1.0 cm3, respectively. It was demonstrated, that after double administration of 1.0 cm3 of “ARRIAH-AviFluVac” vaccine, the post-vaccinal avian influenza antibody level exceeded 5.0 log2 in 75.9–90.0% of the geese population. The most appropriate way of the vaccine use in turkeys, ducks and geese involves at least its double administration at the double commercial dose. Higher species resistance of ducks to the challenge with avian influenza virus of subtype H5, clade 2.3.4.4bas compared to turkeys was also demonstrated.
format Article
id doaj-art-bd8b8180ddcb46fa90430ef424d601f6
institution Kabale University
issn 2304-196X
2658-6959
language English
publishDate 2024-09-01
publisher Da Vinci Media
record_format Article
series Ветеринария сегодня
spelling doaj-art-bd8b8180ddcb46fa90430ef424d601f62025-02-06T09:52:10ZengDa Vinci MediaВетеринария сегодня2304-196X2658-69592024-09-0113324825410.29326/2304-196X-2024-13-3-248-254680Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducksN. V. Moroz0S. V. Frolov1V. N. Irza2L. O. Scherbakova3V. Yu. Kulakov4Federal Centre for Animal HealthFederal Centre for Animal HealthFederal Centre for Animal HealthFederal Centre for Animal HealthFederal Centre for Animal Health“ARRIAH-AviFluVac” vaccine against H5 avian influenza was demonstrated to be effective for  ducks, geese and turkeys both in the laboratory and production environment. When administered to ducks at 0.5; 1.0 and 1.5 cm3, the vaccine provided 100%-effective protection of birds against the disease and death after challenge with the relevant high pathogenicity avian influenza virus of subtype H5N1, clade 2.3.4.4b. Singular 0.5–1.5 cm3 inoculation induced formation of antibodies, which were detected in the hemagglutination inhibition test at the titres that ranged from 4.3 to 6.1 log2. The vaccine facilitated 9–26-fold decrease in the virulent virus shedding by the ducks. Protection of turkeys vaccinated at the dose of 1.0 cm3 was maintained at the level of 87.5% after challenge with high pathogenicity avian influenza virus of subtype H5N1, clade 2.3.4.4b. The vaccine induced formation of antibodies at the titres of 4.9 and 5.5 log2 in turkeys after singular and double vaccination at the dose of 1.0 cm3, respectively. It was demonstrated, that after double administration of 1.0 cm3 of “ARRIAH-AviFluVac” vaccine, the post-vaccinal avian influenza antibody level exceeded 5.0 log2 in 75.9–90.0% of the geese population. The most appropriate way of the vaccine use in turkeys, ducks and geese involves at least its double administration at the double commercial dose. Higher species resistance of ducks to the challenge with avian influenza virus of subtype H5, clade 2.3.4.4bas compared to turkeys was also demonstrated.https://veterinary.arriah.ru/jour/article/view/845high pathogenicity avian influenzah5 avian influenza virusinactivated vaccineimmunogenicityducksgeeseturkeys
spellingShingle N. V. Moroz
S. V. Frolov
V. N. Irza
L. O. Scherbakova
V. Yu. Kulakov
Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks
Ветеринария сегодня
high pathogenicity avian influenza
h5 avian influenza virus
inactivated vaccine
immunogenicity
ducks
geese
turkeys
title Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks
title_full Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks
title_fullStr Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks
title_full_unstemmed Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks
title_short Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks
title_sort use of arriah avifluvac vaccine in turkeys geese and ducks
topic high pathogenicity avian influenza
h5 avian influenza virus
inactivated vaccine
immunogenicity
ducks
geese
turkeys
url https://veterinary.arriah.ru/jour/article/view/845
work_keys_str_mv AT nvmoroz useofarriahavifluvacvaccineinturkeysgeeseandducks
AT svfrolov useofarriahavifluvacvaccineinturkeysgeeseandducks
AT vnirza useofarriahavifluvacvaccineinturkeysgeeseandducks
AT loscherbakova useofarriahavifluvacvaccineinturkeysgeeseandducks
AT vyukulakov useofarriahavifluvacvaccineinturkeysgeeseandducks